bluuebunny/crossref_metadata_2025_split huggingface dataset:
Evaluating Risk Factors for Developing Hypoglycemia During Treatment of Hyperkalemia With Intravenous Regular Insulin
Authors: Beard Meghan M. , McKenzie Jeffrey J. , Potter Terry G. , Varney Gill Kimberly 
Published: January 2024

Background: The conventional dose of 10 units of intravenous (IV) regular insulin to treat hyperkalemia has been associated with hypoglycemia. There have been retrospective studies evaluating weight-based dose vs conventional dose of IV regular insulin but the comparative efficacy and safety is not well established. Objective: Evaluate the difference in weight-based dosing of IV regular insulin between patients who experienced hypoglycemia vs. patients who did not experience hypoglycemia after the administration of IV regular insulin. Methods: This was a retrospective, electronic chart review at a single academic medical center which included patients ≥18 years of age with an emergency department or inpatient encounter who were administered IV regular insulin within 6 hours of a pre-treatment potassium of ≥5 mmol/L. Results: There was no significant difference in the weight-based insulin dose between patients who experienced a hypoglycemic event and patients who did not experience a hypoglycemic event (.14 vs .22 units/kg; P = .44). The potassium-lowering effect was similar between the two groups (1.02 vs .96 mmol/L; P = .56). A regression analysis revealed that female sex, low baseline blood glucose (glucose <140 mg/dL), and those who received a repeat dose of IV regular insulin were independent risk factors for development of hypoglycemia. Conclusion: This study found no difference in hypoglycemic events and potassium lowering based on IV weight-based regular insulin dosing, however other risk factors may predict hypoglycemia.
Incidence and Predictors of Preterm Mortality in Ethiopia: A Systematic Review and Meta-analysis
Authors: Solbana Lencho Kajela , Etana Diriba , Nazi Desalegn , Regea Firaol , Berhanu Solomon 
Published: January 2024

Introduction Preterm birth complication is the first leading cause of neonatal mortality in Ethiopia. In this study, the pooled prevalence and predictors of preterm mortality in Ethiopia were assessed. Methods The research protocol was registered to PROSPERO under the CRD42023415334 registration number. PubMed, Google Scholar, Cochrane Library, and Hinari databases were searched for studies up to April 10, 2023. Cohort studies on the incidence of preterm mortality and its predictors in Ethiopia were included in this review. This review was reported using the preferred reporting items for systematic reviews and meta-analyses checklist. We extracted data from the selected papers and exported to R 4.2.3 and STATA version 15.0 for estimating pooled incidence proportion, density rate, and adjusted hazard ratio (AHR). By looking at the funnel plot and using Egger’s test, the publication bias was assessed. This study didn’t receive funds from any organization. Results From 152 identified studies, 16 studies were selected for final analysis. The pooled incidence proportion and incidence density of preterm mortality were 30% (95% CI: 27%–32%) and 40 (95% CI: 30–40) per 1,000-person days, respectively. Being a male (AHR = 1.43, 95% CI: 1.09, 1.78), gestational age (0.83, 95% CI: 0.80, 0.87), born before 32 weeks (AHR = 2.15, 95% CI: 1.15, 3.84), antepartum hemorrhage (AHR = 2.46, 95% CI: 1.07, 3.84), the fifth minute Apgar rating less than seven (AHR = 1.84, 95% CI: 1.43, 2.25), birth asphyxia (AHR = 1.87, 95% CI; 1.59, 2.14), birth weight 1,000–1,499 g (AHR = 3.63, 95% CI: 1.69, 5.57), respiratory distress syndrome (AHR = 1.80, 95% CI: 1.59, 2.02), jaundice (AHR = 2.39, 95% CI: 1.16, 3.61), neonatal sepsis (AHR = 1.54, 95% CI: 1.25, 1.83), and not using kangaroo mother care (AHR =1.92, 95% CI: 1.11, 2.72) were predictors of time to death of preterm. Conclusions Almost one third of preterm neonates treated at different health facilities in Ethiopia failed to survive to the first four weeks of life. Because every study that was included was an institution-based cohort study, the results may not generalized to preterm newborns who were not hospitalized at medical facilities.
Assessing the effectiveness of gabapentin in paclitaxel-induced arthralgia, myalgia, and neuropathic pain: An observational, cohort study
Authors: Patel Prashantkumar , Rajput Hemraj Singh , Chavda Khushboo , Mistry Smit , Bhagat Sandesh , Hadia Rajesh , Saiyed Moinuddin , Khadela Avinash 
Published: January 2024

Background and objectives Arthralgia, myalgia, and neuropathic pain are the most common side effects observed due to paclitaxel chemotherapy. The aim of this study was to investigate the prophylactic role, maintenance, remission, and re-occurrence of arthralgia, myalgia, and neuropathic pain post-gabapentin therapy. Methodology This study was conducted in the Department of Oncology, Dhiraj Hospital, Vadodara with a sample of 51 patients. Newly detected cancer patients who observed arthralgia, myalgia, and neuropathic pain due to paclitaxel were taken and a baseline pain assessment was done using the Common Terminology Criteria for Adverse Events (CTCAE) and painDETECT questionnaire. Gabapentin was given in the first cycle after symptoms appeared and prophylactic treatment was given in the subsequent three cycles and evaluation of pain was done post-gabapentin therapy to assess the symptomatic as well as prophylactic effect. Results At baseline, neuropathic pain score was 22.7 ± 3.6 which reduced to 0.01 ± 0.14 on subsequent follow-ups. Grade 2 arthralgia, myalgia, and neuropathic pain were more observed at baseline which reduces to Grade 0 in the third cycle. The difference in baseline and post-gabapentin therapy was statistically analyzed by conducting t-test which showed p-value <0.00001 and t-value was less than −2 which indicated a statistically significant result. Conclusion This study shows that gabapentin reduces neuropathic pain. Prophylactic usage of gabapentin was highly effective at bringing about quick pain relief when compared to symptomatic treatment. In further follow-ups, it was noted that gabapentin maintained the impact throughout the cycles.
Treating Executive Function in Youth With Attention Deficit Hyperactivity Disorder: A Review of Pharmacological and Non-Pharmacological Interventions
Authors: Wilens Timothy E. , Stone Mira , Lanni Sylvia , Berger Amy , Wilson Ronan L. H. , Lydston Melis , Surman Craig B. 
Published: January 2024

Introduction:Executive function (EF) deficits are common in youth with ADHD and pose significant functional impairments. The extent and effect of interventions addressing EF in youth with ADHD remain unclear.Methods:We conducted a systematic literature review using PRISMA guidelines. Included studies were randomized controlled trials of interventions to treat EF in youth with ADHD.Results:Our search returned 136 studies representing 11,443 study participants. We identified six intervention categories: nonstimulant pharmacological ( N = 3,576 participants), neurological ( N = 1,935), psychological ( N = 2,387), digital ( N = 2,416), physiological ( N = 680), and combination ( N = 366). The bulk of the evidence supported pharmacological interventions as most effective in mitigating EF, followed by psychological and digital interventions.Conclusion:A breadth of treatments exists for EF in youth with ADHD. Pharmacological, psychotherapeutic, and digital interventions had the most favorable, replicable outcomes. A lack of outcome standardization across studies limited treatment comparison. More data on the persistence of intervention effects are necessary.
Sex hormone therapy in Multiple Sclerosis: A systematic review of randomized clinical trials
Authors: Shayestehfar Monir , Salari Mehri , Karimi Shahedeh , Vosough Massoud , Memari Amirhossein , Nabavi Seyed Massood 
Published: January 2024

Background In spite of the observed immunomodulatory properties of different sex hormones on Multiple Sclerosis (MS) in different investigations, to date, there has been no study to systematically review the documents to add more powerful data to the field. Objectives Therefore, in this paper we aim to systematically review clinical and randomized controlled trials (RCT) assessing the effect of sex hormone therapies on individuals with MS. Design A comprehensive search of electronic databases including PubMed, EMBASE, and Scopus was conducted. Clinical trials and RCTs that assessed the impact of sex hormones on individuals with MS were selected and included in the systematic review. Data sources and methods In the final phase of the search strategy, 9 papers reached the criteria for entering in the systematic review. Two independent reviewers extracted the relevant data from each article according to the standardized data extraction form. Two reviewers also assessed the quality of each study independently using PEDro scale. Results We categorized three different classifications of outcomes including clinical, MRI, and immune system findings and put each measured outcome in the category which matched best. Conclusion In conclusion, the existed investigations on the effect of sex hormones on inflammatory and neurodegenerative components of MS are promising particularly in relapsing-remitting MS (RRMS).
A Prospective Multi-Centered Registry-Based Observational Study for Patients With Cancer: Design and Rationale for Korean Medicine Cancer Registry (KMCARE)
Authors: Lee Jee Young , Jin Hayun , Park Su Bin , Kim Eun Hye , Yoon Jee-Hyun , Yoon Seong Woo 
Published: January 2024

Background: Cancer is one of the leading causes of death in most countries with an expected increased burden on healthcare systems. Since integrative medical treatments are not collected within the scope of existing cancer registries, the establishment of the Korean Medicine Cancer Registry (KMCARE), gathering integrative therapies, including conservative care and Korean medicine, is warranted. Methods: A prospective observational study based on the registry will be conducted in 5 Korean medical hospitals. A total of 650 eligible participants undergoing Korean medicine treatments within 1 month of a diagnosis of lung, colorectal, stomach, or breast cancer are anticipated to be enrolled in the registry. Data collected in the KMCARE can be classified into patient information, received treatments, and outcomes. The primary outcome is the Functional Assessment of Cancer Therapy-General Questionnaire score at 3 months. Secondary outcomes include the MD Anderson Symptom Inventory-Core and the Body Constitution Questionnaire at 3 and 6 months. After 6 months of follow-up periods, survival surveillance will be continued for additional 18 months. Descriptive and statistical analysis of primary and secondary outcomes, baseline data, safety, survival, and prognostic factors will be performed. Discussion: This is the first prospective, multi-centered, registry-based observational study of cancer patients in Korean medicine hospitals, which could reveal the current status of cancer patients receiving integrative cancer therapies, and provide better insight into the role of Korean medicine in palliative care for patients with cancer. Trial registration: Clinical Research Information Service (CRIS), KCT0007447.
Outcomes and Complications of Intramedullary Metacarpal Fixation
Authors: Hoelscher Victoria S. , Milhoan Madison , Quiring Mark , Fix Kassidy , Dalton Stewart , Pientka William F. 
Published: January 2024

Background: Metacarpal fractures are common orthopedic injuries with potentially debilitating outcomes. Ideal surgical treatment remains a topic of debate, with intramedullary fixation becoming popular as a technique to allow for earlier mobilization with few reported complications. The aim of this study was to report observed outcomes and complications of intramedullary metacarpal fixation using the ExsoMed INnate metacarpal nail. Methods: A retrospective chart review of 37 patients with 44 metacarpals treated with the ExsoMed INnate between July 2020 and December 2021 by a single fellowship-trained hand surgeon at a single level 1 trauma center was performed. Variables recorded included both patient and injury demographics, surgical complications, and postoperative outcomes. We also measured metacarpal isthmus diameter of the second to fifth metacarpals on all patients to determine the intramedullary canal diameter to assist in implant size selection. Results: Average follow-up was 5.84 weeks with average time to radiographic healing of 5.5 weeks, and time to full activity 6.32 weeks. The mean postsurgical active total arc of motion was 250°, while passive total arc of motion was 259.74°. A total of 10 complications (22%) were identified, including 4 bent screws which occurred as a result of a punching event postoperatively. Conclusions: Intramedullary fixation of metacarpal fractures using the ExsoMed INnate metacarpal nail has shown to preserve range of motion and quick return to full activity, with a low rate of major complications. Our study highlights the potential major complication of the bent intramedullary screw and its association with an initial punching mechanism.
Referral rates and barriers to lung transplantation based on pulmonary function criteria in interstitial lung diseases: a retrospective cohort study
Authors: Deri Ofir , Ovadia David , Huszti Ella , Peled Michael , Saute Milton , Hod Tammy , Onn Amir , Seluk Lior , Furie Nadav , Shafran Inbal , Mass Ronen , Chatterji Sumit , Levy Liran 
Published: January 2024

Background: Interstitial lung diseases (ILD) unresponsive to medical therapy often require lung transplantation (LTx), which prolongs quality of life and survival. Ideal timing for referral for LTx remains challenging, with late referral associated with significant morbidity and mortality. Among other criteria, patients with ILD should be considered for LTx if forced vital capacity (FVC) is less than 80% or diffusion capacity for carbon monoxide (DLCO) is less than 40%. However, data on referral rates are lacking. Objectives: To evaluate referral rates for LTx based on pulmonary function tests (PFTs) and identify barriers associated with non-referral. Design: A single-center retrospective cohort study. Methods: The study consisted of ILD patients who performed PFT between 2014 and 2020. Patients with FVC < 80% or a DLCO < 40% were included in the study. Patients with absolute contraindications to LTx were excluded. Referral rates were computed, and a comparison was made between referred and non-referred subjects. Results: Out of 114 ILD patients meeting criteria for referral to LTx, 35 were referred (30.7%), and 7 proceeded to undergo LTx. Median time from PFT to referral for assessment was 255 days [interquartile range (IQR) 35–1077]. Median time from referral to LTx was 89 days (IQR 59–143). Referred patients were younger ( p = 0.003), had lower FVC ( p < 0.001), DLCO ( p < 0.001), and a higher rate of pulmonary hypertension ( p = 0.04). Relatively better PFT, and older age, were significantly associated with non-referral of patients. Conclusion: There is under-referral of ILD patients who are eligible for LTx, which is associated with severe disease and missed opportunities for LTx. Further research is required to validate these findings.
Potential Beneficial Effects of Salvianic Acid A and Salvianolic Acid B in Skin Whitening
Authors: Sun Haifeng , Shen Ying , Zhang Ying , Zhou Lei 
Published: January 2024

Objective Natural product-derived biomaterials are highly desired as possible ingredients in cosmetics, as they are often safe and effective. Salvianic acid A (SAA) and salvianolic acid B (SAB) are the primary water-soluble ingredients of Salvia miltiorrhiza Bunge ( Lamiaceae). These compounds have extensive applications as both effective and biocompatible bioactive agents for the treatment of various diseases including cardiovascular disorders, liver ailments, and neuroprotection. This study aimed to evaluate the skin-whitening effects of SAA and SAB on co-cultured human melanoma A375 cells and human keratinocytes HaCaT cells, with the intention of investigating their potential as cosmetic ingredients. Methods First, we assessed the SAA and SAB's efficacy on cells proliferation using MTT assay, as well as their inhibition on intracellular tyrosinase (TYR) activity. Next, we evaluated their effects on the mRNA expression levels of TYR and its related proteins. Furthermore, the whitening efficacy of SAA and SAB was assessed by observing the decrease in melanin content in treated human amalignant melanoma A375 and human keratinocyte HaCaT cells. Results Both SAA and SAB inhibited the activity of TYR and decreased the mRNA expression of TYR-related proteins, thereby inhibiting melanin synthesis. Conclusion Our results suggest that both SAA and SAB can be applied as natural and novel cosmetics materials having a whitening function, which could be beneficial in the cosmeceutical industry.
Predicting delirium and the effects of medications in hospitalized COVID-19 patients using machine learning: A retrospective study within the Korean Multidisciplinary Cohort for Delirium Prevention (KoMCoDe)
Authors: Lee So Hee , Hur Hyun Jung , Kim Sung Nyun , Ahn Jang Ho , Ro Du Hyun , Hong Arum , Park Hye Yoon , Choe Pyoeng Gyun , Kim Back , Park Hye Youn 
Published: January 2024

Objective Delirium is commonly reported from the inpatients with Coronavirus disease 2019 (COVID-19) infection. As delirium is closely associated with adverse clinical outcomes, prediction and prevention of delirium is critical. We developed a machine learning (ML) model to predict delirium in hospitalized patients with COVID-19 and to identify modifiable factors to prevent delirium. Methods The data set (n = 878) from four medical centers was constructed. Total of 78 predictors were included such as demographic characteristics, vital signs, laboratory results and medication, and the primary outcome was delirium occurrence during hospitalization. For analysis, the extreme gradient boosting (XGBoost) algorithm was applied, and the most influential factors were selected by recursive feature elimination. Among the indicators of performance for ML model, the area under the curve of the receiver operating characteristic (AUROC) curve was selected as the evaluation metric. Results Regarding the performance of developed delirium prediction model, the accuracy, precision, recall, F1 score, and the AUROC were calculated (0.944, 0.581, 0.421, 0.485, 0.873, respectively). The influential factors of delirium in this model included were mechanical ventilation, medication (antipsychotics, sedatives, ambroxol, piperacillin/tazobactam, acetaminophen, ceftriaxone, and propacetamol), and sodium ion concentration (all p < 0.05). Conclusions We developed and internally validated an ML model to predict delirium in COVID-19 inpatients. The model identified modifiable factors associated with the development of delirium and could be clinically useful for the prediction and prevention of delirium in COVID-19 inpatients.
Midterm Clinical and Radiological Outcomes of Revision Lateral Meniscal Allograft Transplantation
Authors: Choe Jung-Su , Bin Seong-Il , Kim Jong-Min , Lee Bum-Sik , Song Ju-Ho , Cho Hyung-Kwon , Kee Tae-Hong 
Published: January 2024

Background: It is unknown whether the outcomes achieved in the early period after revision lateral meniscal allograft transplantation (RLMAT) are maintained through the midterm period. Purpose: To evaluate the midterm clinical and radiological results of patients who underwent RLMAT. Study Design: Case series; Level of evidence, 4. Methods: We reviewed the outcomes of 19 RLMATs in 18 patients with at least 5 years of follow-up data. The mean follow-up period was 6 ± 1.1 years (range, 5-8.5 years). Clinical outcomes were assessed using the modified Lysholm score, the International Knee Documentation Committee (IKDC) subjective score, and the Tegner activity level. Radiographic progression of arthritis was measured by the absolute and relative joint space widths on 45° of knee flexion posteroanterior radiographs preoperatively, 1 year postoperatively, and at the latest follow-up.Failure was defined as meniscocapsular separation, removal, or tear of more than half of the meniscal allograft on postoperative magnetic resonance imaging (MRI) or conversion to total knee arthroplasty. Of the 18 patients, 3 underwent ≥2 RLMATs. The survival rate was evaluated according to the number of revision surgeries. Results: For knees with an intact meniscus transplant at the final follow-up, the modified Lysholm and IKDC scores were significantly improved compared with preoperatively, but the Tegner activity level was unchanged. No significant differences were found in the absolute and relative joint space widths postoperatively. There were 6 failures within 3 years after RLMAT; the overall 5-year survival rate was 68.4% (13/19 knees). All failed knees showed bucket-handle tear patterns on MRI due to meniscocapsular healing failure. The survival rate decreased as the number of RLMATs increased—73.3% for a first RLMAT (n = 15 knees), 66.7% for a second RLMAT (n = 3 knees), and 0% for a third RLMAT (n = 1 knee). Midterm MRIs of 8 well-healed RLMATs showed evidence of meniscal degeneration; nonetheless, this did not affect clinical outcomes. Conclusion: The midterm results of RLMATs demonstrated a 5-year survival rate of 68.4% and positive clinical and radiological outcomes for failed MATs despite unimproved activity levels. Inadequate meniscocapsular healing was the leading cause of failure, and it needs to be carefully considered when performing RLMATs.
Cranio-Orbital Oncoplastic Reconstruction in Pediatric Population: Single-Institution’s Experience of 10 Cases
Authors: Skochdopole Anna J. , Layon Sarah A. , Hashemi Ammar S. A. , Yim Nicholas H. , McCarter Jacob H. , Chelius Daniel C. , Pederson William C. , Buchanan Edward P. 
Published: January 2024

Background: Pediatric cranio-orbital tumors have several etiologies and given the broad spectrum of pathology, it is difficult to predict the extent of resection. Reconstruction in children and adolescents is particularly challenging due to potential craniofacial growth and the relatively limited availability of donor sites. In this review, we analyze 10 pediatric and adolescent cases from a single institution, discuss the existing literature, and propose a reconstruction algorithm for managing these complex defects. Methods: A retrospective chart review was performed to identify pediatric and adolescent patients with cranio-orbital tumors who underwent tumor resection and reconstruction at our institution between January 2012 and July 2022. Results: A total of 10 patients underwent oncoplastic reconstruction of defects of either the cranium alone or combination of cranium and orbit, with a mean age of 12.4 years (range: 2-20). The defects involved the parietal (n = 3, 30%), parietooccipital (n = 1; 10%), temporoparietal (n = 1; 10%), occipital (n = 1, 10%), and fronto-orbital (n = 4; 40%) regions. Cranioplasty was performed with split-thickness bone grafts, exchange cranioplasty, or alloplastic materials. A pericranial flap was used to isolate intracranial and extracranial contents in 2 cases. Free flaps were utilized for additional soft tissue coverage in 2 cases. Complications included free flap venous thrombosis, CSF leak, hardware exposure, sagittal sinus injury, superior sagittal sinus thrombosis, vertical diplopia, and hypertropia. Conclusion: The goals of oncoplastic reconstruction for cranio-orbital defects in pediatric and adolescent patients align with those in adults. However, reconstructive surgeons must consider age-specific differences, such as growth potential and limited donor sites. Effective reconstruction can be achieved through meticulous planning, clear communication, and a multidisciplinary approach.